Lisa Peraza - VP, Chief Accounting Officer at HERON THERAPEUTICS, INC. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Chief Accounting Officer
Issuer Symbol
HRTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lisa Peraza since 11 Mar 2025

Holdings reported by Lisa Peraza for HERON THERAPEUTICS, INC. /DE/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 55,907 $120,200 $2.15 13 Jan 2024 Direct
Employee Stock Option (Right to Buy) 41,078 $73,119 $1.78 19 Jan 2024 Direct Common Stock
Restricted Stock Units 6,846 $14,719 $2.15 19 Jan 2024 Direct Common Stock
Performance Stock Units 0 25 Jul 2023 Direct Common Stock

Transactions reported by Lisa Peraza for HERON THERAPEUTICS, INC. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.